Home/Publication/Carlyle to Increase Its Stake in SeQuent via the Sale of Viyash
Carlyle to Increase Its Stake in SeQuent via the Sale of Viyash 

30 Sep 2024

US$ 19.00

The Carlyle Group Inc (Carlyle) is to increase its equity interest in the India-listed SeQuent Scientific Ltd...

Price / article: US$19.00
OR existing subscriber
Related Publications
Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.